NasdaqCM - Nasdaq Real Time Price USD

ImmuCell Corporation (ICCC)

5.27
-0.03
(-0.57%)
At close: May 16 at 4:00:01 PM EDT
5.27
0.00
(0.00%)
After hours: May 16 at 4:05:15 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26,493.17
26,493.17
--
18,567.96
19,242.97
Cost of Revenue
18,552.13
18,552.13
--
10,919.18
10,587.04
Gross Profit
7,941.04
7,941.04
--
7,648.78
8,655.93
Operating Expense
9,581.20
9,581.20
--
9,947.72
8,398.54
Operating Income
-1,640.16
-1,640.16
--
-2,298.94
257.39
Net Non Operating Interest Income Expense
-491.02
-491.02
--
-195.44
-295.55
Other Income Expense
-15.39
-15.39
--
8.25
-30.96
Pretax Income
-2,146.57
-2,146.57
--
-2,486.13
-69.13
Tax Provision
10.06
10.06
--
7.67
9.17
Net Income Common Stockholders
-2,156.63
-2,156.63
--
-2,493.81
-78.29
Diluted NI Available to Com Stockholders
-2,156.63
-2,156.63
--
-2,493.81
-78.29
Basic EPS
-0.26
--
--
-0.32
-0.01
Diluted EPS
-0.26
--
--
-0.32
-0.01
Basic Average Shares
8,167.24
--
7,747.69
7,745
7,592
Diluted Average Shares
8,167.24
--
7,747.69
7,745
7,592
Total Operating Income as Reported
-1,640.16
-1,640.16
--
-2,298.94
257.39
Total Expenses
28,133.33
28,133.33
--
20,866.91
18,985.58
Net Income from Continuing & Discontinued Operation
-2,156.63
-2,156.63
--
-2,493.81
-78.29
Normalized Income
-2,144.47
-2,144.47
-6,056.65
-2,501.12
-55.69
Interest Income
77.70
77.70
--
153.10
18.81
Interest Expense
526.06
526.06
452.98
348.54
306.52
Net Interest Income
-491.02
-491.02
--
-195.44
-295.55
EBIT
-1,620.51
-1,620.51
-5,316.99
-2,137.60
237.39
EBITDA
1,066.67
1,066.67
-2,599.99
349.99
2,698.53
Reconciled Cost of Revenue
18,552.13
18,552.13
--
10,919.18
10,587.04
Reconciled Depreciation
2,687.18
2,687.18
--
2,487.58
2,461.14
Net Income from Continuing Operation Net Minority Interest
-2,156.63
-2,156.63
--
-2,493.81
-78.29
Total Unusual Items Excluding Goodwill
-15.39
-15.39
--
7.33
-30.96
Total Unusual Items
-15.39
-15.39
--
7.33
-30.96
Normalized EBITDA
1,082.06
1,082.06
-2,957.02
342.65
2,729.49
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3.23
-3.23
74.98
0.02
-8.36
12/31/2021 - 5/5/1987

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CSBR Champions Oncology, Inc.
6.35
+1.11%
 
IOT.V Innovotech Inc.
0.1900
+2.70%
 
CTNM Contineum Therapeutics, Inc.
3.5100
-10.91%
 
OND.BE Oncopeptides AB
0.1838
+3.03%
 
DB0.F Q32 Bio Inc.
1.5300
+8.51%
 
PRRUF Immutep Limited
0.2200
0.00%
 
DRMA Dermata Therapeutics, Inc.
0.7910
-0.38%
 
NOX.AX Noxopharm Limited
0.0700
+4.48%
 
ACR.AX Acrux Limited
0.0240
-4.00%
 
BLTE Belite Bio, Inc
64.40
-3.98%